43 related articles for article (PubMed ID: 33773558)
1. Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia.
Kaheled O; Aref S; El Menshawy N; Aref M; Ayed M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4301-4307. PubMed ID: 38156867
[TBL] [Abstract][Full Text] [Related]
2. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells.
Saxena A; Rai A; Raina V; Seth T; Mitra DK
Cancer Immunol Immunother; 2010 Jan; 59(1):125-35. PubMed ID: 19562339
[TBL] [Abstract][Full Text] [Related]
4. Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings.
Menon H; Singh PK; Bagal B; Dolai T; Jain A; Chaudhri A
Indian J Hematol Blood Transfus; 2024 Jan; 40(1):1-11. PubMed ID: 38312181
[TBL] [Abstract][Full Text] [Related]
5. Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions.
Romo-Rodríguez R; Zamora-Herrera G; López-Blanco JA; López-García L; Rosas-Cruz A; Alfaro-Hernández L; Trejo-Pichardo CO; Alberto-Aguilar DR; Casique-Aguirre D; Vilchis-Ordoñez A; Solis-Poblano JC; García-Stivalet LA; Terán-Cerqueda V; Luna-Silva NC; Garrido-Hernández MÁ; Cano-Cuapio LS; Ayala-Contreras K; Domínguez F; Del Campo-Martínez MLÁ; Juárez-Avendaño G; Balandrán JC; Pérez-Tapia SM; Fernández-Giménez C; Zárate-Rodríguez PA; López-Aguilar E; Treviño-García A; Duque-Molina C; Bonifaz LC; Núñez-Enríquez JC; Cárdenas-González M; Álvarez-Buylla ER; Ramírez-Ramírez D; Pelayo R
Front Oncol; 2023; 13():1304662. PubMed ID: 38250553
[TBL] [Abstract][Full Text] [Related]
6. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions.
Qiu L; Wang SA; Tang G; Wang W; Lin P; Xu J; Yin CC; Khanlari M; Medeiros LJ; Li S
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765805
[TBL] [Abstract][Full Text] [Related]
7. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.
Qiu L; Xu J; Lin P; Cohen EN; Tang G; Wang SA; Khanlari M; Wang W; Khoury JD; Konoplev S; Yin CC; Jorgensen JL; Vega F; Medeiros LJ; Li S
Haematologica; 2023 Mar; 108(3):895-899. PubMed ID: 36325892
[No Abstract] [Full Text] [Related]
8. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
9. CD34 is not Expressed by Blasts in a Third of B-ALL Patients and its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis.
Garg N; Gupta R; Kotru M
Asian Pac J Cancer Prev; 2021 Mar; 22(3):919-925. PubMed ID: 33773558
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
11. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
Hann IM; Richards SM; Eden OB; Hill FG
Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
